Effects of Thrombin Infusions upon ¹³¹I‐labelled Fibrinogen in Dogs

Bleeding Due to Increased Intravascular Blood Coagulation

1965 • 197 citations

Excessive consumption of blood coagulation components as cause of hemorrhagic diathesis

1965 • 141 citations

Studies on the Plasma Fibrinolytic Activity in a Case of Liver Cirrhosis

1960 • 93 citations

Platelet and Fibrinogen Survival in Normal and Abnormal States of Coagulation

1961 • 84 citations

Inhibition of Fibrinolytic and Thromboplastic Activity by Trasylol®

1966 • 56 citations

Turnover of ¹³¹I‐Labelled Fibrinogen in Man: Studies in Normal Subjects, in Congenital Coagulation Factor Deficiency States, in Liver Cirrhosis, in Polycythemia Vera and in Epidermolysis Bullosa¹

1966 • 54 citations

Studies concerning the turnover of fibrinogen I-131 in the dog.

1961 • 41 citations

Occult intravascular clotting by means of intravenous injection of thrombin

1959 • 37 citations

Further Experience With the Use of Thrombin as a Hemostatic Agent

1939 • 36 citations

Effects of intravenous tissue thromboplastin in dogs: development of an anticoagulant.

1962 • 36 citations

Circulating Fibrinogen Degradation Products (FDP) in Dog Blood after Intravenous Thrombin Infusion

1965 • 29 citations

Changes in fibrinogen level after infusion of thrombin and thromboplastin

1960 • 22 citations

EXPERIMENTAL INVESTIGATIONS ON THE ANTITHROMBOPLASTIC AND ANTIFIBRINOLYTIC ACTIVITY OF TRASYLOL®

1968 • 20 citations

In vitro inhibition of streptokinase-induced proteolysis by Trasylol and by epsilon amino caproic acid (EACA).

1965 • 13 citations

Disseminated Intravascular Coagulation

2020 • 4 citations